Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Acetylcysteine
Alliance Healthcare (Distribution) Ltd
R05CB01
Acetylcysteine
600mg
Capsule
No Controlled Drug Status
Valid as a prescribable product
BNF: 03070000
Mucolight 600mg Capsules (Acetylcysteine) PACKAGE LEAFLET: INFORMATION FOR THE USER ! If you are allergic to histamine. If you are not able to tolerate food and drinks that contain large amounts of histamine such as wine, tomatoes or processed food, then Mucolight Capsules are not suitable for you because acetylcysteine affects how histamine is broken down in the body. The most common symptoms of histamine intolerance are migraine headaches, flushing, hives and rhinitis (stuffy, runny nose) and itching. ! If you have asthma WARNINGS AND PRECAUTIONS Serious skin rashes (Steven-Johnson syndrome and Lyell's syndrome) have rarely been reported with the use of acetylcysteine. The rash can often involve ulcers of the mouth, throat, nose, genitals Talk to your doctor, pharmacist or nurse before taking Mucolight Capsules: ! If you have a history of stomach ulcers ! If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. ! Are under 14 years of age 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MUCOLIGHT CAPSULES 4. POSSIBLE SIDE EFFECTS ! ARE ALLERGIC TO ACETYLCYSTEINE or any of the other ingredients of this medicine (listed in section 6) Mucolight Capsules contain a medicine called acetylcysteine. This belongs to a group of medicines called mucolytics. It works by making the mucus (phlegm) less sticky which makes the mucus easier to cough up. Acetylcysteine is used for problems with the breathing passages (respiratory tract). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MUCOLIGHT CAPSULES 1. WHAT MUCOLIGHT CAPSULES ARE AND WHAT THEY ARE USED FOR 1. WHAT MUCOLIGHT CAPSULES ARE AND WHAT THEY ARE USED FOR ! If you have any further questions, ask your doctor, pharmacist or nurse. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. ! This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the sa Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Mucolight 600mg Capsules Acetylcysteine 600mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 600 mg acetylcysteine. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Almost white, crystalline powder, filled in white hard gelatin 00 Capsule size. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Mucolight 600mg Capsules are a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterized by excessive, viscous mucus, including chronic obstructive airways disease. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION In general the usual recommended dosage is: Adults including elderly and adolescents 14 years and older: 600 mg (1 capsule) once daily. Duration of therapy: the duration of therapy is dependent on the nature and severity of the illness and should be decided by the doctor. For oral use. Swallow the capsule with a drink of water. The capsule should be taken after food. Hepatic and Renal Impairment In patients with impaired kidney or liver function there is insufficient data on whether dosage adjustments are required. Hepatic and renal impairment can reduce clearance which may result in an increase in adverse drug reactions due to drug accumulation. 4.3 CONTRAINDICATIONS Hypersensitivity to acetylcysteine or to any of the excipients listed in section 6.1. This medicine should not be used in children under 14 years of age. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Serious skin reactions such as Stevens-Johnson syndrome and Lyell’s syndrome have been reported whilst taking acetylcysteine, but these occur rarely. For this reason, medical advice should be sought immediately and the patient should stop taking acetylcysteine in the event of new-onset changes to the skin and mucous membranes. See also section 4.8. There are no studies on the efficacy and safety of once daily acetylcysteine 600 mg capsule in the adolescent population. However, mild, moderate or severe adverse react Read the complete document